‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize May 26, 2021 Peter McCusker Company Stories 0 Comments LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan and Neil Mahapatra were two of the UK’s first cannabis entrepreneurs, entering the space in 2015. It didn’t take long… Read More→
British Biotech Firm To List on the London Stock Exchange With A Valuation of Over £50m May 18, 2021 Peter McCusker EMEA 0 Comments BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value it at £51.5m It says it will raise £16.5m from a ‘heavily oversubscribed’ initial public offering and enter the market… Read More→